Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates

A new category of cefepime susceptibility, susceptible dose dependent (SDD), for Enterobacteriaceae, has been suggested to maximize its clinical use. However, clinical evidence supporting such a therapeutic strategy is limited. A retrospective study of 305 adults with monomicrobial Enterobacter cloa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Lee, Nan-Yao, Lee, Ching-Chi, Li, Chia-Wen, Li, Ming-Chi, Chen, Po-Lin, Chang, Chia-Ming, Ko, Wen-Chien
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2015
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4649147/
https://ncbi.nlm.nih.gov/pubmed/26416853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01477-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires